FAQ

Hallucinogens

Known as: Psychotomimetic Agents, psychedelic drug, Hallucinogenic Agents 
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1954-2017
010020019542016

Related topics

Related topics

36 relations

Narrower (19)

2,5-Dimethoxy-4-methylamphetamine2,5-dimethoxy-4-bromoamphetamine3,4-Methylenedioxyamphetamine4-iodo-2,5-dimethoxyphenylisopropylamine
(More)
CannabinoidsCannabisCholinergic AntagonistsHallucinations
(More)

Broader (3)

Central Nervous System AgentsPharmaceutical Preparationspsychopharmacologic agent

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Hallucinogens
agonists
3,4-Methylenedioxyamphetamine
Cannabinoids
Hallucinations
Cannabis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator.
The sigma-1 receptor is widely distributed in the central nervous system and periphery. Originally mischaracterized as an opioid… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
Hallucinogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognition… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Cannabinoids Potentiate Emotional Learning Plasticity in Neurons of the Medial Prefrontal Cortex through Basolateral Amygdala Inputs.
Cannabinoids represent one of the most commonly used hallucinogenic drug classes. In addition, cannabis use is a primary risk… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.
OBJECTIVE Data on use and misuse of six classes of illicit substances by male twin pairs were used to examine whether genetic and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
Salvia divinorum, whose main active ingredient is the neoclerodane diterpene Salvinorin A, is a hallucinogenic plant in the mint… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins.
BACKGROUND In order to develop informed approaches to prevention and treatment of illicit psychoactive substance use, abuse, and… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities.
BACKGROUND Previous research has demonstrated genetic and environmental influences on abuse of individual substances, but there… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine.
The effects of the psychotomimetic drug phencyclidine on the neurochemistry and function of the prefrontal cortex in vervet… (More)
Is this relevant?
Highly Cited
1989
Highly Cited
1989
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs.
Phencyclidine (PCP), a dissociative anesthetic and widely abused psychotomimetic drug, and MK-801, a potent PCP receptor ligand… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens
Alterations in brain serotonergic function have been implicated in the mechanism of action of LSD, mescaline, and other similarly… (More)
  • table 1
Is this relevant?